We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Withdraws cGMP Rule Exempting Phase I Studies
FDA Withdraws cGMP Rule Exempting Phase I Studies
May 5, 2006
Criticism from a variety of stakeholders has led the FDA to withdraw its direct final rule exempting most investigational drugs from complying with current Good Manufacturing Practices (cGMP).